These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29724921)

  • 21. Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.
    Paterniti MO; Bi Y; Rekić D; Wang Y; Karimi-Shah BA; Chowdhury BA
    Ann Am Thorac Soc; 2017 Sep; 14(9):1395-1402. PubMed ID: 28388260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis.
    Canestaro WJ; Forrester SH; Raghu G; Ho L; Devine BE
    Chest; 2016 Mar; 149(3):756-66. PubMed ID: 26836914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.
    Jo HE; Glaspole I; Grainge C; Goh N; Hopkins PM; Moodley Y; Reynolds PN; Chapman S; Walters EH; Zappala C; Allan H; Keir GJ; Hayen A; Cooper WA; Mahar AM; Ellis S; Macansh S; Corte TJ
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias?
    Suissa S
    Diabetes Care; 2018 Jan; 41(1):6-10. PubMed ID: 29263192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
    Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins and lower mortality in rheumatic diseases: An effect of immortal time bias?
    Abrahami D; Hudson M; Suissa S
    Semin Arthritis Rheum; 2021 Feb; 51(1):211-218. PubMed ID: 33385861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes in idiopathic pulmonary fibrosis: a meta-analysis from placebo controlled trials.
    Atkins CP; Loke YK; Wilson AM
    Respir Med; 2014 Feb; 108(2):376-87. PubMed ID: 24440032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
    Klingsberg RC; Mutsaers SE; Lasky JA
    Respirology; 2010 Jan; 15(1):19-31. PubMed ID: 20199632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic pulmonary fibrosis: increased survival with "gastroesophageal reflux therapy": fact or fallacy?
    Raghu G
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1330-2. PubMed ID: 22174112
    [No Abstract]   [Full Text] [Related]  

  • 30. All-cause mortality rate in patients with idiopathic pulmonary fibrosis. Implications for the design and execution of clinical trials.
    King TE; Albera C; Bradford WZ; Costabel U; du Bois RM; Leff JA; Nathan SD; Sahn SA; Valeyre D; Noble PW
    Am J Respir Crit Care Med; 2014 Apr; 189(7):825-31. PubMed ID: 24476390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis.
    Ghebremariam YT; Cooke JP; Gerhart W; Griego C; Brower JB; Doyle-Eisele M; Moeller BC; Zhou Q; Ho L; de Andrade J; Raghu G; Peterson L; Rivera A; Rosen GD
    J Transl Med; 2015 Aug; 13():249. PubMed ID: 26231702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What's new with stress ulcer prophylaxis in the ICU?
    Marker S; Krag M; Møller MH
    Intensive Care Med; 2017 Aug; 43(8):1132-1134. PubMed ID: 28238056
    [No Abstract]   [Full Text] [Related]  

  • 33. Proton pump inhibitors therapy vs H2 receptor antagonists therapy for upper gastrointestinal bleeding after endoscopy: A meta-analysis.
    Zhang YS; Li Q; He BS; Liu R; Li ZJ
    World J Gastroenterol; 2015 May; 21(20):6341-51. PubMed ID: 26034370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.
    Covvey JR; Mancl EE
    Ann Pharmacother; 2014 Dec; 48(12):1611-9. PubMed ID: 25202034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and adverse events of pirfenidone in treating idiopathic pulmonary fibrosis.
    Ren H; Wang K; Yang H; Gao L
    Saudi Med J; 2017 Sep; 38(9):889-894. PubMed ID: 28889145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Pirfenidone in Idiopathic Pulmonary Fibrosis - A Longitudinal Cohort Study.
    Suraj KP; Kumar NK; Jyothi E; Narayan KV; Biju G
    J Assoc Physicians India; 2016 May; 64(5):36-41. PubMed ID: 27735147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
    Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
    Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis.
    Kreuter M; Bonella F; Maher TM; Costabel U; Spagnolo P; Weycker D; Kirchgaessler KU; Kolb M
    Thorax; 2017 Feb; 72(2):148-153. PubMed ID: 27708114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.